Showing 1 - 9 results of 9 for search 'I. Tsui', query time: 0.04s
Refine Results
-
1
COVID-19 Stress Is Associated with Increased Smoking among People with HIV in Western Washington: A Cross-Sectional Survey by Anh Tuyet Nguyen, Francis Slaughter, Sarah Smith, David A. Katz, Sandeep Prabhu, Liying Wang, Jane M. Simoni, Judith I. Tsui, Susan M. Graham
Published 2024-09-01
Article -
2
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized... by Elenore P. Bhatraju, Devin N. Kennedy, Alexander J. Gojic, Matthew Iles-Shih, Joseph O. Merrill, Jeffrey H. Samet, Kevin A. Hallgren, Judith I. Tsui
Published 2025-01-01
Article -
3
Systems analysis and improvement to optimize opioid use disorder care quality and continuity for patients exiting jail (SAIA-MOUD) by Sarah Gimbel, Anirban Basu, Emily Callen, Abraham D. Flaxman, Omeid Heidari, Julia E. Hood, Anna Kellogg, Eli Kern, Judith I. Tsui, Ericka Turley, Kenneth Sherr
Published 2024-12-01
Article -
4
Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled... by Sebastian T. Tong, Kris Pui Kwan Ma, Ajla Pleho, Brennan Keiser, Chialing Hsu, Dawn M. Ehde, Mary C. Curran, Judith I. Tsui, Patrick J. Raue, Kari A. Stephens
Published 2024-09-01
Article -
5
Opioid risk-reduction strategies for people with HIV on chronic opioid therapy: A qualitative study of patient perspectives by Karsten Lunze, Jennifer J. Carroll, Nishtha Ahuja, Marlene C. Lira, Judith I. Tsui, Alicia Ventura, Jonathan A. Colasanti, Jane M. Liebschutz, Carlos del Rio, Jeffrey H. Samet
Published 2024-12-01
Article -
6
Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Cana... by Lawrence C McCandless, Malcolm Maclure, M Eugenia Socías, Evan Wood, Paul Gustafson, Robert W Platt, Bohdan Nosyk, Sander Greenland, Micah Piske, Trevor Thomson, Emanuel Krebs, Natt Hongdilokkul, Julie Bruneau, M Ehsan Karim, Judith I Tsui
Published 2020-09-01
Article -
7
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study by Snehal S. Lopes, Moonseong Heo, Irene Pericot-Valverde, Brianna L. Norton, Lynn E. Taylor, Judith I. Tsui, Shruti H. Mehta, Judith Feinberg, Arthur Y. Kim, Paula J. Lum, Kimberly Page, Cristina Murray-Krezan, Jessica Anderson, Alain H. Litwin, the HERO Study Group
Published 2024-09-01
Article -
8
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities by Angela T. Estadt, David Kline, William C. Miller, Judith Feinberg, Christopher B. Hurt, L. Sarah Mixson, Peter D. Friedmann, Kelsa Lowe, Judith I. Tsui, April M. Young, Hannah Cooper, P. Todd Korthuis, Mai T. Pho, Wiley Jenkins, Ryan P. Westergaard, Vivian F. Go, Daniel Brook, Gordon Smith, Dylan R. Rice, Kathryn E. Lancaster
Published 2024-11-01
Article -
9
Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics? by Thomas J. Stopka, Robin M. Nance, L. Sarah Mixson, Hunter Spencer, Judith I. Tsui, Judith M. Leahy, Mai T. Pho, Jean DeJace, Judith Feinberg, April M. Young, Wei-Teng Yang, Amelia Baltes, Eric Romo, Randall T. Brown, Kerry Nolte, William C. Miller, William A. Zule, Wiley D. Jenkins, Joseph A. Delaney, Peter D. Friedmann
Published 2025-01-01
Article